Navigation Links
State of the Mangosteen Category: 2009
Date:3/6/2009

Mangosteen category-creator XanGo continues its leadership in product innovation with green skincare application

Next phase of performance research shows XanGo(R) Juice reduces inflammation in obese subjects

Statement by Robert Conlee, CEO of XanGo, LLC

LEHI, Utah, March 6 /PRNewswire/ -- XanGo, LLC, the first company to market a premium mangosteen beverage, continues to lead the superfruit movement. As a global nutrition company, XanGo now reaches 23 countries and is expanding the benefits of the popular mangosteen to new applications. With the launch of Glimpse(TM) Intuitive Skincare, XanGo revisits its category-creating status by introducing the first personal care product to feature the power of the mangosteen at its foundation to deliver the fruit's numerous nutrients through a green, toxin-free formula that protects consumer's health and the environment.

Introducing Innovative, Topical Mangosteen Experience

The development of a personal care brand using mangosteen was a natural progression in the company's growth following last year's introduction of 3SIXTY5(TM), a whole food nutrition mangosteen-based multi-vitamin. In November 2008, XanGo introduced Glimpse Intuitive Skin Care as topical nutrition that is free of harsh chemicals and featuring green chemistry technology in self-adjusting formulas.

One of the formula's driving ingredients is BioActive X(3) Complex(TM), a proprietary ingredient that incorporates an exclusive biofermentation technology that combines meticulous, time-honored techniques with advanced science from Japan to amplify the phytonutrient potency of the mangosteen. The inclusion of these three exclusive ingredients with mangosteen-infused water helps ensure optimum nutrient density in the formulas to further promote the health-giving properties of the mangosteen.

XanGo has made a public commitment to green chemistry by signing the Compact for Safe Cosmetics, by which the company pledges to do no harm and to comply with EU directive 1776 that bans the use of several chemicals popularly used in personal care products in the U.S.

Rising to the Popularity of the Mangosteen

Exotic, nutrient-packed fruits are taking front stage in the natural health marketplace. As the National Restaurant Association reports, superfruits have sustained consumer interest and represent a significant area of growth in 2009. These antioxidant-packed fruits rank 7th among "Top 20" hot trends and 3rd among products in "What's Hot" in a chef survey done by the NRA.

XanGo was able to get ahead of and capitalize on that trend when it introduced the category-creating XanGo(R) Juice just six years ago. Since that time and several new product introductions later, XanGo is now a cumulative $1.5 billion sales company. With more than 1 million direct sales distributors worldwide, XanGo now spans four continents.

Even in a tough economy, XanGo is positioned well as it continues to experience strong sales. Both natural products and direct sales fare well during an economic downturn as evidenced by data released by Information Resources Inc. citing nationwide retail sales of vitamins and supplements that totaled nearly $639 million in the fourth quarter of 2008, a 10 percent jump from 2007. Meanwhile, the direct sales industry operates at 5 percent higher growth than the gross domestic product when the economy contracts, according to the Direct Selling Association. All of which bodes well for XanGo, which fortuitously represents the best of both natural products and direct sales.

Leading Scientific Research on Mangosteen Performance

With scientific partners that include Northridge, Calif.-based Medicus Research, Weber State University and leading independent laboratories, XanGo continues to spearhead scientific exploration of the whole mangosteen fruit through a tiered approach on safety, standardization and efficacy.

In XanGo's most recent independent research of the mangosteen completed in January 2009, promising peer-reviewed clinical trials by the UCLA School of Medicine's Dr. Jay K. Udani have shown that XanGo(R) Juice reduces inflammation in obese subjects, which may be valuable in preventing the progression to diabetes and heart disease. This eight-week randomized, double-blind, placebo-controlled study included a pre-study two-week washout period. It evaluated the effect of multiple dosages of a proprietary mangostoeen juice on indicators of inflammation and antioxidant levels in obese patients with elevated C-reactive protein (CRP) levels.

Previous independent research sponsored by XanGo has demonstrated that the proprietary whole fruit formula in XanGo Juice leads to high levels of xanthone absorption while unnaturally elevated levels of xanthone consumption actually were shown to decrease absorption efficiency.

XanGo is intent on continuing to lead the worldwide market in mangosteen-based research and category-creating mangosteen-based products. Expect more research in the coming years that continues to validate existing claims about the mangosteen and further product extensions that broaden the benefits of the mangosteen to myriad oral, topical and other wellness applications.

About XanGo

A leading global nutrition company, XanGo, LLC is a recognized category creator as the first company to market a premium mangosteen beverage, XanGo(R) Juice, to consumers worldwide. XanGo continues to lead the category by driving the research, development and advancement of functional mangosteen products. It has expanded its roster of premium, functional products to include 3SIXTY5(TM), a whole food nutrition multi-vitamin, along with Glimpse(TM) Intuitive Skin Care. XanGo is privately owned and powered by a global network of 1 million independent distributors in the U.S. and more than 20 international markets such as Canada, Mexico, Japan, Germany and Malaysia. For details, visit www.xango.com.


'/>"/>
SOURCE XanGo, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AHIP Statement on White House Health Care Summit
2. Change to Win Statement on White House Health Care Forum
3. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California, Regarding President Obamas Healthcare Summit
4. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
5. IPRO QIO Uses Milliman Care Guidelines(R) for Medicare Reviews in New York State
6. European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
7. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
8. AAJ Statement on Supreme Court Decision in Favor of Diana Levine
9. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
10. AAHSA Statement on Senate Special Committee on Aging Hearing, Health Reform in an Aging America
11. Naturally Safe Zucol(TM) Brings Europes Leading Cold Remedy to United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology: